[{"received": 1326838373, "issue_codes": ["HCR", "FOR"], "type": "FOURTH QUARTER REPORT", "client_name": "Berna Biotech AG, Bern", "period": "4th Quarter (Oct 1 - Dec 31)", "id": "79ADBA4B-6187-4066-8C7F-404C4DBFCB19", "amount": 20000, "client": {"legal_name": "Berna Biotech AG, Bern", "name": "Crucell Switzerland AG", "naics": "541711", "gvkey": "247573", "ticker": "BBIN", "id": null, "bvdid": "CHCHE105974022"}, "meta": {"79ADBA4B-6187-4066-8C7F-404C4DBFCB19": {"client": {"total": 1}, "specific_issues": {"LKhzhuMm7K2GDsZqH6f4zN": {}, "total": 2, "EGGtRWWMhPNVtn24xZ7bdd": {}}}}, "year": 2011, "specific_issues": [{"text": "Work on policy and procurement matters regarding vaccines", "gov_entities": [" Defense - Dept of (DOD)", " Defense Logistics Agency", " State - Dept of (DOS)", " U.S. Agency for International Development (USAID)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["FETZER, CHRIS", "HAAKE, TIMOTHY"], "year": 2011, "issue": "HCR", "id": "EGGtRWWMhPNVtn24xZ7bdd"}, {"text": "Work on policy and procurement matters regarding vaccines", "gov_entities": [" Defense - Dept of (DOD)", " Defense Logistics Agency", " State - Dept of (DOS)", " U.S. Agency for International Development (USAID)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["FETZER, CHRIS", "HAAKE, TIMOTHY"], "year": 2011, "issue": "FOR", "id": "LKhzhuMm7K2GDsZqH6f4zN"}], "registrant": "HAAKE AND ASSOCIATES", "alternate_name": "Crucell Switzerland AG"}, {"received": 1307993173, "issue_codes": ["HCR", "MED", "FOR"], "type": "REGISTRATION", "client_name": "Berna Biotech AG, Bern", "period": "UNDETERMINED", "id": "8F0AFAE1-3E2E-4CB3-863B-312459BAB253", "amount": null, "client": {"legal_name": "Berna Biotech AG, Bern", "name": "Crucell Switzerland AG", "naics": "541711", "gvkey": "247573", "ticker": "BBIN", "id": null, "bvdid": "CHCHE105974022"}, "meta": {"8F0AFAE1-3E2E-4CB3-863B-312459BAB253": {"client": {"total": 1}, "specific_issues": {"hrkMnSNVeoEW4w49osrL3b": {}, "9kBckMp6cq9xJ4SxHk2Fjm": {}, "total": 3, "aersh6YV2D8ZkNntU7CyyM": {}}}}, "year": 2011, "specific_issues": [{"text": "Work on authorization/ approval, appropriations, and policy matters regarding vaccines.", "issue": "HCR", "id": "9kBckMp6cq9xJ4SxHk2Fjm", "lobbyists": ["FETZER, CHRIS", "HAAKE, TIMOTHY"], "year": 2011}, {"text": "Work on authorization/ approval, appropriations, and policy matters regarding vaccines.", "issue": "FOR", "id": "aersh6YV2D8ZkNntU7CyyM", "lobbyists": ["FETZER, CHRIS", "HAAKE, TIMOTHY"], "year": 2011}, {"text": "Work on authorization/ approval, appropriations, and policy matters regarding vaccines.", "issue": "MED", "id": "hrkMnSNVeoEW4w49osrL3b", "lobbyists": ["FETZER, CHRIS", "HAAKE, TIMOTHY"], "year": 2011}], "registrant": "HAAKE AND ASSOCIATES", "alternate_name": "Crucell Switzerland AG"}, {"received": 1319049630, "issue_codes": ["HCR", "FOR"], "type": "THIRD QUARTER REPORT", "client_name": "Berna Biotech AG, Bern", "period": "3rd Quarter (July 1 - Sep 30)", "id": "BF1D08F0-1B53-4B21-AB87-EAA487923773", "amount": 20000, "client": {"legal_name": "Berna Biotech AG, Bern", "name": "Crucell Switzerland AG", "naics": "541711", "gvkey": "247573", "ticker": "BBIN", "id": null, "bvdid": "CHCHE105974022"}, "meta": {"BF1D08F0-1B53-4B21-AB87-EAA487923773": {"client": {"total": 1}, "specific_issues": {"total": 2, "f4ZVjQReFkYiPyWxK4aTTW": {}, "pb8miY2oiHkSFBC6PtLFw8": {}}}}, "year": 2011, "specific_issues": [{"text": "Work on policy matters regarding vaccines.", "gov_entities": [" Centers For Disease Control & Prevention (CDC)", " Defense - Dept of (DOD)", " State - Dept of (DOS)", " U.S. Agency for International Development (USAID)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["FETZER, CHRIS", "HAAKE, TIM"], "year": 2011, "issue": "HCR", "id": "f4ZVjQReFkYiPyWxK4aTTW"}, {"text": "Work on policy matters regarding vaccines.", "gov_entities": [" Centers For Disease Control & Prevention (CDC)", " Defense - Dept of (DOD)", " State - Dept of (DOS)", " U.S. Agency for International Development (USAID)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["FETZER, CHRIS", "HAAKE, TIM"], "year": 2011, "issue": "FOR", "id": "pb8miY2oiHkSFBC6PtLFw8"}], "registrant": "HAAKE AND ASSOCIATES", "alternate_name": "Crucell Switzerland AG"}, {"received": 1310406762, "issue_codes": ["HCR", "MED", "FOR"], "type": "SECOND QUARTER REPORT", "client_name": "Berna Biotech AG, Bern", "period": "2nd Quarter (Apr 1 - June 30)", "id": "D69E0327-99EC-400E-956F-BC302A4092DD", "amount": 20000, "client": {"legal_name": "Berna Biotech AG, Bern", "name": "Crucell Switzerland AG", "naics": "541711", "gvkey": "247573", "ticker": "BBIN", "id": null, "bvdid": "CHCHE105974022"}, "meta": {"D69E0327-99EC-400E-956F-BC302A4092DD": {"client": {"total": 1}, "specific_issues": {"total": 3, "VmpNjjUCCtb9dmpsanJA8L": {}, "LGytwY3fQ2WgtjwrMUfjzX": {}, "2dnuhymazjRyEjqwpPB5f8": {}}}}, "year": 2011, "specific_issues": [{"text": "Work on authorization/ approval, appropriations, and policy matters regarding vaccines.", "gov_entities": [" Centers For Disease Control & Prevention (CDC)", " Defense - Dept of (DOD)", " State - Dept of (DOS)", " U.S. Agency for International Development (USAID)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["FETZER, CHRIS", "HAAKE, TIM"], "year": 2011, "issue": "HCR", "id": "2dnuhymazjRyEjqwpPB5f8"}, {"text": "Work on authorization/ approval, appropriations, and policy matters regarding vaccines.", "gov_entities": [" Centers For Disease Control & Prevention (CDC)", " Defense - Dept of (DOD)", " State - Dept of (DOS)", " U.S. Agency for International Development (USAID)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["FETZER, CHRIS", "HAAKE, TIM"], "year": 2011, "issue": "FOR", "id": "LGytwY3fQ2WgtjwrMUfjzX"}, {"text": "Work on authorization/ approval, appropriations, and policy matters regarding vaccines.", "gov_entities": [" Centers For Disease Control & Prevention (CDC)", " Defense - Dept of (DOD)", " State - Dept of (DOS)", " U.S. Agency for International Development (USAID)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["FETZER, CHRIS", "HAAKE, TIM"], "year": 2011, "issue": "MED", "id": "VmpNjjUCCtb9dmpsanJA8L"}], "registrant": "HAAKE AND ASSOCIATES", "alternate_name": "Crucell Switzerland AG"}, {"received": 1326841795, "issue_codes": ["HCR", "PHA", "FOR"], "type": "FOURTH QUARTER TERMINATION AMENDMENT", "client_name": "Berna Biotech AG, Bern", "period": "4th Quarter (Oct 1 - Dec 31)", "id": "DE37215E-154A-489F-9D51-61D46F3D36C3", "amount": 20000, "client": {"legal_name": "Berna Biotech AG, Bern", "name": "Crucell Switzerland AG", "naics": "541711", "gvkey": "247573", "ticker": "BBIN", "id": null, "bvdid": "CHCHE105974022"}, "meta": {"DE37215E-154A-489F-9D51-61D46F3D36C3": {"client": {"total": 1}, "specific_issues": {"CbW4zM488ntZJ42S2xVyrV": {}, "total": 3, "GNVGxys8Ge4jxSFearKLyA": {}, "PtdbMekFgaVbgjkHNpdjsY": {}}}}, "year": 2011, "specific_issues": [{"text": "Work on policy and procurement matters related to vaccines", "gov_entities": [" State - Dept of (DOS)", " U.S. Agency for International Development (USAID)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["FETZER, CHRIS", "HAAKE, TIMOTHY"], "year": 2011, "issue": "FOR", "id": "CbW4zM488ntZJ42S2xVyrV"}, {"text": "Work on policy and procurement matters related to vaccines", "gov_entities": [" Defense - Dept of (DOD)", " Defense Logistics Agency", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["FETZER, CHRIS", "HAAKE, TIMOTHY"], "year": 2011, "issue": "HCR", "id": "GNVGxys8Ge4jxSFearKLyA"}, {"text": "Work on policy and procurement matters related to vaccines", "gov_entities": [" Defense - Dept of (DOD)", " Defense Logistics Agency", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["FETZER, CHRIS", "HAAKE, TIMOTHY"], "year": 2011, "issue": "PHA", "id": "PtdbMekFgaVbgjkHNpdjsY"}], "registrant": "HAAKE AND ASSOCIATES", "alternate_name": "Crucell Switzerland AG"}, {"received": 1271442647, "issue_codes": [], "type": "FIRST QUARTER TERMINATION (NO ACTIVITY)", "client_name": "LAURAS AS", "period": "1st Quarter (Jan 1 - Mar 31)", "id": "3EDBCCF0-BA27-479C-A316-A3C705D171F3", "amount": null, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"3EDBCCF0-BA27-479C-A316-A3C705D171F3": {"client": {"total": 1}, "specific_issues": {"DPoVKyt5ji4LXs8nprXrEC": {}, "total": 1}}}, "year": 2010, "specific_issues": [{"text": "", "gov_entities": [], "id": "DPoVKyt5ji4LXs8nprXrEC", "year": 2010}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1248090150, "issue_codes": [], "type": "SECOND QUARTER (NO ACTIVITY)", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "2nd Quarter (Apr 1 - June 30)", "id": "1B47B3F8-E95F-4707-B0D0-0700443EE56D", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"1B47B3F8-E95F-4707-B0D0-0700443EE56D": {"client": {"total": 1}, "specific_issues": {"76hrFzw5SCH3Rnascem8VG": {}, "total": 1}}}, "year": 2009, "specific_issues": [{"text": "", "gov_entities": [], "id": "76hrFzw5SCH3Rnascem8VG", "year": 2009}], "registrant": "The Cohen Group", "alternate_name": "International Golden Group"}, {"received": 1259590528, "issue_codes": [], "type": "THIRD QUARTER TERMINATION AMENDMENT (NO ACTIVITY)", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "3rd Quarter (July 1 - Sep 30)", "id": "35194097-598C-41AF-8490-2466C3560718", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"35194097-598C-41AF-8490-2466C3560718": {"client": {"total": 1}, "specific_issues": {"total": 1, "sCkzo7YeRKNGBpWcrJVcyV": {}}}}, "year": 2009, "specific_issues": [{"text": "", "gov_entities": [], "id": "sCkzo7YeRKNGBpWcrJVcyV", "year": 2009}], "registrant": "The Cohen Group", "alternate_name": "International Golden Group"}, {"received": 1240248568, "issue_codes": ["DEF"], "type": "FOURTH QUARTER REPORT", "client_name": "LYTIX BIOPHARMA AS", "period": "4th Quarter (Oct 1 - Dec 31)", "id": "3FBBE0AC-99AE-436E-9AD8-A9BA40E0850C", "amount": 10000, "client": {"legal_name": "LYTIX BIOPHARMA AS", "name": "LYTEX BIOPHARMA AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO985889635"}, "meta": {"3FBBE0AC-99AE-436E-9AD8-A9BA40E0850C": {"client": {"total": 1}, "specific_issues": {"ps8xwaSBmsZF3LMFTVj37J": {}, "total": 1}}}, "year": 2009, "specific_issues": [{"text": "Provisions relating to cancer research", "gov_entities": ["U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["HIPP, VAN"], "year": 2009, "issue": "DEF", "id": "ps8xwaSBmsZF3LMFTVj37J"}], "registrant": "American Defense International, Inc.", "alternate_name": "LYTEX BIOPHARMA AS"}, {"received": 1242769070, "issue_codes": ["DEF"], "type": "FIRST QUARTER REPORT", "client_name": "LYTIX BIOPHARMA AS", "period": "1st Quarter (Jan 1 - Mar 31)", "id": "641C1799-F464-47E4-BA12-8A7340955E96", "amount": 10000, "client": {"legal_name": "LYTIX BIOPHARMA AS", "name": "LYTEX BIOPHARMA AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO985889635"}, "meta": {"641C1799-F464-47E4-BA12-8A7340955E96": {"client": {"total": 1}, "specific_issues": {"total": 1, "atoDjAmjBX3yFiuoeGkPBS": {}}}}, "year": 2009, "specific_issues": [{"text": "Provisions relating to cancer research", "gov_entities": ["U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["HIPP, VAN"], "year": 2009, "issue": "DEF", "id": "atoDjAmjBX3yFiuoeGkPBS"}], "registrant": "American Defense International, Inc.", "alternate_name": "LYTEX BIOPHARMA AS"}, {"received": 1255551170, "issue_codes": [], "type": "THIRD QUARTER (NO ACTIVITY)", "client_name": "LAURAS AS", "period": "3rd Quarter (July 1 - Sep 30)", "id": "4E9D5B4D-502F-43A6-9370-1481DCDB5875", "amount": null, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"4E9D5B4D-502F-43A6-9370-1481DCDB5875": {"client": {"total": 1}, "specific_issues": {"PXkEYG4piEm5U6CyNt2rKn": {}, "total": 1}}}, "year": 2009, "specific_issues": [{"text": "", "gov_entities": [], "id": "PXkEYG4piEm5U6CyNt2rKn", "year": 2009}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1247750598, "issue_codes": [], "type": "SECOND QUARTER (NO ACTIVITY)", "client_name": "LAURAS AS", "period": "2nd Quarter (Apr 1 - June 30)", "id": "709880A2-78BB-41E4-98F0-8C77BA1DCCEC", "amount": null, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"709880A2-78BB-41E4-98F0-8C77BA1DCCEC": {"client": {"total": 1}, "specific_issues": {"Vtxi7GXF8zegJ4Eyv8x37U": {}, "total": 1}}}, "year": 2009, "specific_issues": [{"text": "", "gov_entities": [], "id": "Vtxi7GXF8zegJ4Eyv8x37U", "year": 2009}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1263508105, "issue_codes": [], "type": "FOURTH QUARTER (NO ACTIVITY)", "client_name": "LAURAS AS", "period": "4th Quarter (Oct 1 - Dec 31)", "id": "80D6AB20-3EFD-4BC2-B65D-464258986AF9", "amount": null, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"80D6AB20-3EFD-4BC2-B65D-464258986AF9": {"client": {"total": 1}, "specific_issues": {"total": 1, "J5QmuMhBiWKJsrg9F9WSp4": {}}}}, "year": 2009, "specific_issues": [{"text": "", "gov_entities": [], "id": "J5QmuMhBiWKJsrg9F9WSp4", "year": 2009}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1289251067, "issue_codes": [], "type": "FOURTH QUARTER TERMINATION (NO ACTIVITY)", "client_name": "LYTIX BIOPHARMA AS", "period": "4th Quarter (Oct 1 - Dec 31)", "id": "8F02CEE2-1094-4C66-9358-9B6D241E71A0", "amount": null, "client": {"legal_name": "LYTIX BIOPHARMA AS", "name": "LYTEX BIOPHARMA AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO985889635"}, "meta": {"8F02CEE2-1094-4C66-9358-9B6D241E71A0": {"client": {"total": 1}, "specific_issues": {"JnVuNSQhzXeSPFKgRpYXMb": {}, "total": 1}}}, "year": 2009, "specific_issues": [{"text": "", "gov_entities": [], "id": "JnVuNSQhzXeSPFKgRpYXMb", "year": 2009}], "registrant": "American Defense International, Inc.", "alternate_name": "LYTEX BIOPHARMA AS"}, {"received": 1239973165, "issue_codes": [], "type": "FIRST QUARTER (NO ACTIVITY)", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "1st Quarter (Jan 1 - Mar 31)", "id": "AB498E4E-2A84-4FEC-95AE-E0B348CECD5E", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"AB498E4E-2A84-4FEC-95AE-E0B348CECD5E": {"client": {"total": 1}, "specific_issues": {"total": 1, "5qzmpsGDR3jSP9KLCaBBVm": {}}}}, "year": 2009, "specific_issues": [{"text": "", "gov_entities": [], "id": "5qzmpsGDR3jSP9KLCaBBVm", "year": 2009}], "registrant": "The Cohen Group", "alternate_name": "International Golden Group"}, {"received": 1239042119, "issue_codes": ["DEF"], "type": "FIRST QUARTER REPORT", "client_name": "LAURAS AS", "period": "1st Quarter (Jan 1 - Mar 31)", "id": "AA2F35D9-151D-48E2-B553-368D1F3D5A53", "amount": null, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"AA2F35D9-151D-48E2-B553-368D1F3D5A53": {"client": {"total": 1}, "specific_issues": {"4rEWSVSZdXUYqp9EiBDrXN": {}, "total": 1}}}, "year": 2009, "specific_issues": [{"text": "Immunostimulating HIV Therapy", "gov_entities": ["U.S. HOUSE OF REPRESENTATIVES"], "lobbyists": ["VOGEL, MICHELLE"], "year": 2009, "issue": "DEF", "id": "4rEWSVSZdXUYqp9EiBDrXN"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1240139757, "issue_codes": ["HCR"], "type": "FIRST QUARTER TERMINATION", "client_name": "OXITEC LIMITED", "period": "1st Quarter (Jan 1 - Mar 31)", "id": "B1F3ECAE-2038-4A0E-9BBD-A94196BA9F31", "amount": 10000, "client": {"legal_name": "OXITEC LIMITED", "name": "Oxitec", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "GB04512301"}, "meta": {"B1F3ECAE-2038-4A0E-9BBD-A94196BA9F31": {"client": {"total": 1}, "specific_issues": {"total": 1, "pVgpWQiZquL7hmDcRvpDQX": {}}}}, "year": 2009, "specific_issues": [{"text": "issues related to biotechnology and biological insect control solution using sterilization techniques", "gov_entities": [" Agriculture - Dept of (USDA)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " White House Office"], "lobbyists": ["ALBERT, ALEX", "HANNESSCHLAGER, JENNIFER"], "year": 2009, "issue": "HCR", "id": "pVgpWQiZquL7hmDcRvpDQX"}], "registrant": "McKenna, Long & Aldridge", "alternate_name": "Oxitec"}, {"received": 1256044625, "issue_codes": [], "type": "THIRD QUARTER (NO ACTIVITY)", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "3rd Quarter (July 1 - Sep 30)", "id": "DEBE4DDE-F3E8-47C0-8B61-D18327533790", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"DEBE4DDE-F3E8-47C0-8B61-D18327533790": {"client": {"total": 1}, "specific_issues": {"total": 1, "TTgUh3ZQvBarSEFn6eLwkF": {}}}}, "year": 2009, "specific_issues": [{"text": "", "gov_entities": [], "id": "TTgUh3ZQvBarSEFn6eLwkF", "year": 2009}], "registrant": "The Cohen Group", "alternate_name": "International Golden Group"}, {"received": 1247750659, "issue_codes": [], "type": "SECOND QUARTER TERMINATION (NO ACTIVITY)", "client_name": "LYTIX BIOPHARMA AS", "period": "2nd Quarter (Apr 1 - June 30)", "id": "E6047A8A-643A-4632-9A6E-9415873B3B1F", "amount": null, "client": {"legal_name": "LYTIX BIOPHARMA AS", "name": "LYTEX BIOPHARMA AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO985889635"}, "meta": {"E6047A8A-643A-4632-9A6E-9415873B3B1F": {"client": {"total": 1}, "specific_issues": {"fBgGZPyAK3S8BYucGdHMiQ": {}, "total": 1}}}, "year": 2009, "specific_issues": [{"text": "", "gov_entities": [], "id": "fBgGZPyAK3S8BYucGdHMiQ", "year": 2009}], "registrant": "American Defense International, Inc.", "alternate_name": "LYTEX BIOPHARMA AS"}, {"received": 1216994523, "issue_codes": [], "type": "SECOND QUARTER AMENDMENT (NO ACTIVITY)", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "2nd Quarter (Apr 1 - June 30)", "id": "34440ADE-DB06-4DED-9ECE-7961A4B5682D", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"34440ADE-DB06-4DED-9ECE-7961A4B5682D": {"client": {"total": 1}, "specific_issues": {"MSiMrzm6C8yf9XwXpKmFF7": {}, "total": 1}}}, "year": 2008, "specific_issues": [{"text": "", "gov_entities": [], "id": "MSiMrzm6C8yf9XwXpKmFF7", "year": 2008}], "registrant": "The Cohen Group", "alternate_name": "International Golden Group"}, {"received": 1208469004, "issue_codes": ["DEF"], "type": "FIRST QUARTER REPORT", "client_name": "LAURAS AS", "period": "1st Quarter (Jan 1 - Mar 31)", "id": "400DE5E1-DD38-4B79-943F-A0C1CC3E7E9F", "amount": null, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"400DE5E1-DD38-4B79-943F-A0C1CC3E7E9F": {"client": {"total": 1}, "specific_issues": {"total": 1, "oUGsz48G5D6vi7ETGqDqBP": {}}}}, "year": 2008, "specific_issues": [{"text": "Department of Defense Appropriations Bill, provisions relating to HIV therapy.National Defense Authorization Act, provisions relating to HIV therapy.", "gov_entities": ["U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["PRESNELL, SISSY"], "year": 2008, "issue": "DEF", "id": "oUGsz48G5D6vi7ETGqDqBP"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1232401947, "issue_codes": ["VET", "BUD", "DEF"], "type": "THIRD QUARTER TERMINATION AMENDMENT", "client_name": "BIOTIE THERAPIES AG", "period": "3rd Quarter (July 1 - Sep 30)", "id": "425789A8-D0EC-4E50-A62D-0B62D68BDA87", "amount": 20000, "client": {"legal_name": "BIOTIE THERAPIES AG", "name": "SYNOSIA THERAPEUTICS INC", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "CHCHE113909392"}, "meta": {"425789A8-D0EC-4E50-A62D-0B62D68BDA87": {"client": {"total": 1}, "specific_issues": {"U6XmaN9FgJahghEZ5gb2XR": {}, "VQXueWvhsfTTo9RwkzHZtm": {}, "total": 3, "xgsTrhE2QSa6QXv6fUAu2H": {}}}}, "year": 2008, "specific_issues": [{"text": "Congressionally Directed Medical Research Programs within the Department of Defense FY08 budget and DOD Appropriations for FY09, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics and Post Traumatic Stress Disorder research.", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["MCCAIN, STEVEN", "RITTER, DANIEL"], "year": 2008, "issue": "BUD", "id": "U6XmaN9FgJahghEZ5gb2XR"}, {"text": "Congressionally Directed Medical Research Programs within the Department of Defense FY08 budget and DOD Appropriations for FY09, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics and Post Traumatic Stress Disorder research.", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["MCCAIN, STEVEN", "RITTER, DANIEL"], "year": 2008, "issue": "DEF", "id": "VQXueWvhsfTTo9RwkzHZtm"}, {"text": "Congressionally Directed Medical Research Programs within the Department of Defense FY08 budget and DOD Appropriations for FY09, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics and Post Traumatic Stress Disorder research.", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["MCCAIN, STEVEN", "RITTER, DANIEL"], "year": 2008, "issue": "VET", "id": "xgsTrhE2QSa6QXv6fUAu2H"}], "registrant": "K&L GATES LLP", "alternate_name": "SYNOSIA THERAPEUTICS INC"}, {"received": 1208642360, "issue_codes": ["HCR"], "type": "FIRST QUARTER REPORT", "client_name": "OXITEC LIMITED", "period": "1st Quarter (Jan 1 - Mar 31)", "id": "496E00FA-3024-4B3F-A69C-7FE6A7BD4297", "amount": 50000, "client": {"legal_name": "OXITEC LIMITED", "name": "Oxitec", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "GB04512301"}, "meta": {"496E00FA-3024-4B3F-A69C-7FE6A7BD4297": {"client": {"total": 1}, "specific_issues": {"total": 1, "ToXANLHuKAKuy3LqJP4eCW": {}}}}, "year": 2008, "specific_issues": [{"text": "issues related to biotechnology and biological insect control solution using sterilization techniques", "gov_entities": [" Agriculture - Dept of (USDA)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " White House Office"], "lobbyists": ["ALBERT, ALEX", "HANNESSCHLAGER, JENNIFER"], "year": 2008, "issue": "HCR", "id": "ToXANLHuKAKuy3LqJP4eCW"}], "registrant": "McKenna, Long & Aldridge", "alternate_name": "Oxitec"}, {"received": 1231883125, "issue_codes": [], "type": "FOURTH QUARTER (NO ACTIVITY)", "client_name": "LAURAS AS", "period": "4th Quarter (Oct 1 - Dec 31)", "id": "65336249-32C5-44E0-AEB0-CB9F7970D160", "amount": null, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"65336249-32C5-44E0-AEB0-CB9F7970D160": {"client": {"total": 1}, "specific_issues": {"total": 1, "WAFDoPU59KaKSX5Bjrfdnc": {}}}}, "year": 2008, "specific_issues": [{"text": "", "gov_entities": [], "id": "WAFDoPU59KaKSX5Bjrfdnc", "year": 2008}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1231868941, "issue_codes": [], "type": "FOURTH QUARTER (NO ACTIVITY)", "client_name": "LYTIX BIOPHARMA AS", "period": "4th Quarter (Oct 1 - Dec 31)", "id": "6D75A5F9-9A6E-4DBB-877C-EB9295EC107D", "amount": null, "client": {"legal_name": "LYTIX BIOPHARMA AS", "name": "LYTEX BIOPHARMA AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO985889635"}, "meta": {"6D75A5F9-9A6E-4DBB-877C-EB9295EC107D": {"client": {"total": 1}, "specific_issues": {"total": 1, "aWq6FKNQYdQXyz2qQGb3C6": {}}}}, "year": 2008, "specific_issues": [{"text": "", "gov_entities": [], "id": "aWq6FKNQYdQXyz2qQGb3C6", "year": 2008}], "registrant": "American Defense International, Inc.", "alternate_name": "LYTEX BIOPHARMA AS"}, {"received": 1224273550, "issue_codes": ["DEF"], "type": "THIRD QUARTER REPORT", "client_name": "LAURAS AS", "period": "3rd Quarter (July 1 - Sep 30)", "id": "80EE89D2-0472-4E71-9602-C0A659E6E412", "amount": null, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"80EE89D2-0472-4E71-9602-C0A659E6E412": {"client": {"total": 1}, "specific_issues": {"5fnXcqNuztkNbb9a9XsiYZ": {}, "total": 1}}}, "year": 2008, "specific_issues": [{"text": "PRovisions relating to HIV therapy", "gov_entities": ["U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["HIPP, VAN"], "year": 2008, "issue": "DEF", "id": "5fnXcqNuztkNbb9a9XsiYZ"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1216675419, "issue_codes": ["HCR"], "type": "SECOND QUARTER REPORT", "client_name": "OXITEC LIMITED", "period": "2nd Quarter (Apr 1 - June 30)", "id": "7DD5D198-D5C7-4814-B4FF-49EFD5B52F65", "amount": 50000, "client": {"legal_name": "OXITEC LIMITED", "name": "Oxitec", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "GB04512301"}, "meta": {"7DD5D198-D5C7-4814-B4FF-49EFD5B52F65": {"client": {"total": 1}, "specific_issues": {"total": 1, "FSxm6Aaxga35VLqxMPxvyC": {}}}}, "year": 2008, "specific_issues": [{"text": "issues related to biotechnology and biological insect control solution using sterilization techniques", "gov_entities": [" Agriculture - Dept of (USDA)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " White House Office"], "lobbyists": ["ALBERT, ALEX", "HANNESSCHLAGER, JENNIFER"], "year": 2008, "issue": "HCR", "id": "FSxm6Aaxga35VLqxMPxvyC"}], "registrant": "McKenna, Long & Aldridge", "alternate_name": "Oxitec"}, {"received": 1216664712, "issue_codes": [], "type": "SECOND QUARTER (NO ACTIVITY)", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "2nd Quarter (Apr 1 - June 30)", "id": "07DE96D6-0D83-4EBB-A6B1-B541454FAE22", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"07DE96D6-0D83-4EBB-A6B1-B541454FAE22": {"client": {"total": 1}, "specific_issues": {"UgsnKeGNAAxAqRnRkzax9j": {}, "total": 1}}}, "year": 2008, "specific_issues": [{"text": "", "gov_entities": [], "id": "UgsnKeGNAAxAqRnRkzax9j", "year": 2008}], "registrant": "The Cohen Group", "alternate_name": "International Golden Group"}, {"received": 1208371317, "issue_codes": ["VET", "BUD", "DEF"], "type": "FIRST QUARTER REPORT", "client_name": "BIOTIE THERAPIES AG", "period": "1st Quarter (Jan 1 - Mar 31)", "id": "061EE0A2-CEEC-438E-AEB5-7BD1AB23D023", "amount": 20000, "client": {"legal_name": "BIOTIE THERAPIES AG", "name": "SYNOSIA THERAPEUTICS INC", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "CHCHE113909392"}, "meta": {"061EE0A2-CEEC-438E-AEB5-7BD1AB23D023": {"client": {"total": 1}, "specific_issues": {"U5e2XEZdXsHGpmTKKEwKZk": {"bills_by_algo": {"total": 1, "110_HR3222": {"sponsor": {"total": 1}}}}, "total": 3, "ENEo5Z4S3AHD5gmhCwTLNc": {"bills_by_algo": {"total": 1, "110_HR3222": {"sponsor": {"total": 1}}}}, "wFn9u6wyLtfkAaVbrWXnsa": {"bills_by_algo": {"total": 1, "110_HR3222": {"sponsor": {"total": 1}}}}}}}, "year": 2008, "specific_issues": [{"text": "Congressionally Directed Medical Research Programs and HR 3222, DOD Appropriations for FY08 and FY 2009, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics. Post Traumatic Stress Disorder Research.", "id": "ENEo5Z4S3AHD5gmhCwTLNc", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["HEIMAN, BRUCE", "MCCAIN, STEVEN", "OLIVARES, EDWARD", "RITTER, DANIEL", "STIMERS, PAUL"], "year": 2008, "issue": "VET", "bills_by_algo": [{"public_law": "110-116", "titles": ["Making appropriations for the Department of Defense for the fiscal year ending September 30, 2008, and for other purposes.", "Department of Defense Appropriations Act, 2008", "Border Security First Act of 2007", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008"], "top_terms": ["Armed forces and national security", "AIDS (Disease)"], "number": 3222, "session": 110, "sponsor": {"firstname": "John", "district": 12, "title": "rep", "lastname": "Murtha", "religion": "Catholic", "state": "PA", "gender": "M", "party": "Democrat", "id": 400286}, "committees": ["House Appropriations", "Senate Appropriations"], "introduced": 1185768000, "type": "HR", "id": "110_HR3222"}]}, {"text": "Congressionally Directed Medical Research Programs and HR 3222, DOD Appropriations for FY08 and FY 2009, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics. Post Traumatic Stress Disorder Research.", "id": "U5e2XEZdXsHGpmTKKEwKZk", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["HEIMAN, BRUCE", "MCCAIN, STEVEN", "OLIVARES, EDWARD", "RITTER, DANIEL", "STIMERS, PAUL"], "year": 2008, "issue": "DEF", "bills_by_algo": [{"public_law": "110-116", "titles": ["Making appropriations for the Department of Defense for the fiscal year ending September 30, 2008, and for other purposes.", "Department of Defense Appropriations Act, 2008", "Border Security First Act of 2007", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008"], "top_terms": ["Armed forces and national security", "AIDS (Disease)"], "number": 3222, "session": 110, "sponsor": {"firstname": "John", "district": 12, "title": "rep", "lastname": "Murtha", "religion": "Catholic", "state": "PA", "gender": "M", "party": "Democrat", "id": 400286}, "committees": ["House Appropriations", "Senate Appropriations"], "introduced": 1185768000, "type": "HR", "id": "110_HR3222"}]}, {"text": "Congressionally Directed Medical Research Programs and HR 3222, DOD Appropriations for FY08 and FY 2009, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics. Post Traumatic Stress Disorder Research.", "id": "wFn9u6wyLtfkAaVbrWXnsa", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["HEIMAN, BRUCE", "MCCAIN, STEVEN", "OLIVARES, EDWARD", "RITTER, DANIEL", "STIMERS, PAUL"], "year": 2008, "issue": "BUD", "bills_by_algo": [{"public_law": "110-116", "titles": ["Making appropriations for the Department of Defense for the fiscal year ending September 30, 2008, and for other purposes.", "Department of Defense Appropriations Act, 2008", "Border Security First Act of 2007", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008"], "top_terms": ["Armed forces and national security", "AIDS (Disease)"], "number": 3222, "session": 110, "sponsor": {"firstname": "John", "district": 12, "title": "rep", "lastname": "Murtha", "religion": "Catholic", "state": "PA", "gender": "M", "party": "Democrat", "id": 400286}, "committees": ["House Appropriations", "Senate Appropriations"], "introduced": 1185768000, "type": "HR", "id": "110_HR3222"}]}], "registrant": "K&L GATES LLP", "alternate_name": "SYNOSIA THERAPEUTICS INC"}, {"received": 1232383273, "issue_codes": [], "type": "FOURTH QUARTER (NO ACTIVITY)", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "4th Quarter (Oct 1 - Dec 31)", "id": "22206656-F7A7-4129-93FC-907FA3484B1E", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"22206656-F7A7-4129-93FC-907FA3484B1E": {"client": {"total": 1}, "specific_issues": {"Jy3u8j9heqnRRYCFgXCxnf": {}, "total": 1}}}, "year": 2008, "specific_issues": [{"text": "", "gov_entities": [], "id": "Jy3u8j9heqnRRYCFgXCxnf", "year": 2008}], "registrant": "The Cohen Group", "alternate_name": "International Golden Group"}, {"received": 1255373312, "issue_codes": [], "type": "SECOND QUARTER (NO ACTIVITY)", "client_name": "LAURAS AS", "period": "2nd Quarter (Apr 1 - June 30)", "id": "2EC25CBE-05AF-4DB7-BAC5-43204CDE6BD5", "amount": null, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"2EC25CBE-05AF-4DB7-BAC5-43204CDE6BD5": {"client": {"total": 1}, "specific_issues": {"total": 1, "bup8hjRn6hiAmBWCCqBNyE": {}}}}, "year": 2008, "specific_issues": [{"text": "", "gov_entities": [], "id": "bup8hjRn6hiAmBWCCqBNyE", "year": 2008}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1232228473, "issue_codes": ["HCR"], "type": "FOURTH QUARTER REPORT", "client_name": "OXITEC LIMITED", "period": "4th Quarter (Oct 1 - Dec 31)", "id": "17D8E00F-62C2-4795-99BE-2A472CDA41B2", "amount": 10000, "client": {"legal_name": "OXITEC LIMITED", "name": "Oxitec", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "GB04512301"}, "meta": {"17D8E00F-62C2-4795-99BE-2A472CDA41B2": {"client": {"total": 1}, "specific_issues": {"k8VirEzUY52hJF3EQkSBMP": {}, "total": 1}}}, "year": 2008, "specific_issues": [{"text": "issues related to biotechnology and biological insect control solution using sterilization techniques", "gov_entities": [" Agriculture - Dept of (USDA)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " White House Office"], "lobbyists": ["ALBERT, ALEX", "HANNESSCHLAGER, JENNIFER"], "year": 2008, "issue": "HCR", "id": "k8VirEzUY52hJF3EQkSBMP"}], "registrant": "McKenna, Long & Aldridge", "alternate_name": "Oxitec"}, {"received": 1208540094, "issue_codes": ["DEF"], "type": "FIRST QUARTER REPORT", "client_name": "LYTIX BIOPHARMA AS", "period": "1st Quarter (Jan 1 - Mar 31)", "id": "96E30C37-37B9-4179-8D8B-4E17C42205CF", "amount": 10000, "client": {"legal_name": "LYTIX BIOPHARMA AS", "name": "LYTEX BIOPHARMA AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO985889635"}, "meta": {"96E30C37-37B9-4179-8D8B-4E17C42205CF": {"client": {"total": 1}, "specific_issues": {"6H8QBzCpVqA9CSfs87v2UZ": {}, "total": 1}}}, "year": 2008, "specific_issues": [{"text": "Department of Defense Appropriations Bill, provisions relating to antimicrobial and novel cancer drugs.National Defense Authorization Act, provisions relating to antimicrobial and novel cancer drugs.", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE"], "lobbyists": ["ELTZROTH, KATE"], "year": 2008, "issue": "DEF", "id": "6H8QBzCpVqA9CSfs87v2UZ"}], "registrant": "American Defense International, Inc.", "alternate_name": "LYTEX BIOPHARMA AS"}, {"received": 1203016668, "issue_codes": ["HCR"], "type": "REGISTRATION", "client_name": "OXITEC LIMITED", "period": "UNDETERMINED", "id": "B2A2725D-8AD6-4B42-9B2B-FB76F454C395", "amount": null, "client": {"legal_name": "OXITEC LIMITED", "name": "Oxitec", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "GB04512301"}, "meta": {"B2A2725D-8AD6-4B42-9B2B-FB76F454C395": {"client": {"total": 1}, "specific_issues": {"62a7mTcfWzUN37BqEvk6iM": {}, "total": 1}}}, "year": 2008, "specific_issues": [{"text": "issues related to biotechnology and biological insect control solutions using sterilization techniques", "issue": "HCR", "id": "62a7mTcfWzUN37BqEvk6iM", "lobbyists": ["ALBERT, ALEX", "HANNESSCHLAGER, JENNIFER"], "year": 2008}], "registrant": "McKenna, Long & Aldridge", "alternate_name": "Oxitec"}, {"received": 1224260805, "issue_codes": ["VET", "DEF", "BUD"], "type": "THIRD QUARTER REPORT", "client_name": "BIOTIE THERAPIES AG", "period": "3rd Quarter (July 1 - Sep 30)", "id": "C3CDA449-6C8A-4BAD-A892-63490A819910", "amount": 20000, "client": {"legal_name": "BIOTIE THERAPIES AG", "name": "SYNOSIA THERAPEUTICS INC", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "CHCHE113909392"}, "meta": {"C3CDA449-6C8A-4BAD-A892-63490A819910": {"client": {"total": 1}, "specific_issues": {"hQr8Kgox4H4R8M8aga23Rj": {}, "total": 3, "ZyjySqqpaaFvFWsHHibB9X": {}, "uzvUf5AFm9QfNHrToK8Toe": {}}}}, "year": 2008, "specific_issues": [{"text": "Congressionally Directed Medical Research Programs within the Department of Defense FY08 budget and DOD Appropriations for FY09, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics and Post Traumatic Stress Disorder research.", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["MCCAIN, STEVEN", "RITTER, DANIEL"], "year": 2008, "issue": "DEF", "id": "hQr8Kgox4H4R8M8aga23Rj"}, {"text": "Congressionally Directed Medical Research Programs within the Department of Defense FY08 budget and DOD Appropriations for FY09, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics and Post Traumatic Stress Disorder research.", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["MCCAIN, STEVEN", "RITTER, DANIEL"], "year": 2008, "issue": "BUD", "id": "uzvUf5AFm9QfNHrToK8Toe"}, {"text": "Congressionally Directed Medical Research Programs within the Department of Defense FY08 budget and DOD Appropriations for FY09, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics and Post Traumatic Stress Disorder research.", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["MCCAIN, STEVEN", "RITTER, DANIEL"], "year": 2008, "issue": "VET", "id": "ZyjySqqpaaFvFWsHHibB9X"}], "registrant": "K&L GATES LLP", "alternate_name": "SYNOSIA THERAPEUTICS INC"}, {"received": 1224532903, "issue_codes": ["HCR"], "type": "THIRD QUARTER REPORT", "client_name": "OXITEC LIMITED", "period": "3rd Quarter (July 1 - Sep 30)", "id": "C5C3A761-66D3-4CB4-94AE-5A2AB3B2D7C7", "amount": 10000, "client": {"legal_name": "OXITEC LIMITED", "name": "Oxitec", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "GB04512301"}, "meta": {"C5C3A761-66D3-4CB4-94AE-5A2AB3B2D7C7": {"client": {"total": 1}, "specific_issues": {"kmWqVsCHTDf2V3UTLcCT3a": {}, "total": 1}}}, "year": 2008, "specific_issues": [{"text": "issues related to biotechnology and biological insect control solution using sterilization techniques", "gov_entities": [" Agriculture - Dept of (USDA)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " White House Office"], "lobbyists": ["ALBERT, ALEX", "HANNESSCHLAGER, JENNIFER"], "year": 2008, "issue": "HCR", "id": "kmWqVsCHTDf2V3UTLcCT3a"}], "registrant": "McKenna, Long & Aldridge", "alternate_name": "Oxitec"}, {"received": 1224529830, "issue_codes": [], "type": "THIRD QUARTER (NO ACTIVITY)", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "3rd Quarter (July 1 - Sep 30)", "id": "C0DA31A8-0B8F-4439-B0E3-2550B2482F60", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"C0DA31A8-0B8F-4439-B0E3-2550B2482F60": {"client": {"total": 1}, "specific_issues": {"W3TKxgbCDzBFaM9ToJ7ah7": {}, "total": 1}}}, "year": 2008, "specific_issues": [{"text": "", "gov_entities": [], "id": "W3TKxgbCDzBFaM9ToJ7ah7", "year": 2008}], "registrant": "The Cohen Group", "alternate_name": "International Golden Group"}, {"received": 1216656673, "issue_codes": ["VET", "DEF", "BUD"], "type": "SECOND QUARTER REPORT", "client_name": "BIOTIE THERAPIES AG", "period": "2nd Quarter (Apr 1 - June 30)", "id": "DC0B9DE7-F8EC-45DC-8412-BA7FCF024216", "amount": 20000, "client": {"legal_name": "BIOTIE THERAPIES AG", "name": "SYNOSIA THERAPEUTICS INC", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "CHCHE113909392"}, "meta": {"DC0B9DE7-F8EC-45DC-8412-BA7FCF024216": {"client": {"total": 1}, "specific_issues": {"total": 3, "kb4JNZ2983qmXbyYvgpK7J": {"bills_by_algo": {"total": 1, "110_HR3222": {"sponsor": {"total": 1}}}}, "jFbpP58o4rqURkGByWQL8R": {"bills_by_algo": {"total": 1, "110_HR3222": {"sponsor": {"total": 1}}}}, "5inkftxAA8boUQnqahakyZ": {"bills_by_algo": {"total": 1, "110_HR3222": {"sponsor": {"total": 1}}}}}}}, "year": 2008, "specific_issues": [{"text": "Congressionally Directed Medical Research Programs and HR 3222, DOD Appropriations for FY08 and FY 2009, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics. Post Traumatic Stress Disorder Research.", "id": "5inkftxAA8boUQnqahakyZ", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["MCCAIN, STEVEN", "RITTER, DANIEL"], "year": 2008, "issue": "BUD", "bills_by_algo": [{"public_law": "110-116", "titles": ["Making appropriations for the Department of Defense for the fiscal year ending September 30, 2008, and for other purposes.", "Department of Defense Appropriations Act, 2008", "Border Security First Act of 2007", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008"], "top_terms": ["Armed forces and national security", "AIDS (Disease)"], "number": 3222, "session": 110, "sponsor": {"firstname": "John", "district": 12, "title": "rep", "lastname": "Murtha", "religion": "Catholic", "state": "PA", "gender": "M", "party": "Democrat", "id": 400286}, "committees": ["House Appropriations", "Senate Appropriations"], "introduced": 1185768000, "type": "HR", "id": "110_HR3222"}]}, {"text": "Congressionally Directed Medical Research Programs and HR 3222, DOD Appropriations for FY08 and FY 2009, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics. Post Traumatic Stress Disorder Research.", "id": "jFbpP58o4rqURkGByWQL8R", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["MCCAIN, STEVEN", "RITTER, DANIEL"], "year": 2008, "issue": "VET", "bills_by_algo": [{"public_law": "110-116", "titles": ["Making appropriations for the Department of Defense for the fiscal year ending September 30, 2008, and for other purposes.", "Department of Defense Appropriations Act, 2008", "Border Security First Act of 2007", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008"], "top_terms": ["Armed forces and national security", "AIDS (Disease)"], "number": 3222, "session": 110, "sponsor": {"firstname": "John", "district": 12, "title": "rep", "lastname": "Murtha", "religion": "Catholic", "state": "PA", "gender": "M", "party": "Democrat", "id": 400286}, "committees": ["House Appropriations", "Senate Appropriations"], "introduced": 1185768000, "type": "HR", "id": "110_HR3222"}]}, {"text": "Congressionally Directed Medical Research Programs and HR 3222, DOD Appropriations for FY08 and FY 2009, explore potential federal business development opportunities including grants, contracts and appropriations for medical therapeutics. Post Traumatic Stress Disorder Research.", "id": "kb4JNZ2983qmXbyYvgpK7J", "gov_entities": [" Defense - Dept of (DOD)", "U.S. HOUSE OF REPRESENTATIVES", " U.S. SENATE", " Veterans Affairs - Dept of (VA)"], "lobbyists": ["MCCAIN, STEVEN", "RITTER, DANIEL"], "year": 2008, "issue": "DEF", "bills_by_algo": [{"public_law": "110-116", "titles": ["Making appropriations for the Department of Defense for the fiscal year ending September 30, 2008, and for other purposes.", "Department of Defense Appropriations Act, 2008", "Border Security First Act of 2007", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008"], "top_terms": ["Armed forces and national security", "AIDS (Disease)"], "number": 3222, "session": 110, "sponsor": {"firstname": "John", "district": 12, "title": "rep", "lastname": "Murtha", "religion": "Catholic", "state": "PA", "gender": "M", "party": "Democrat", "id": 400286}, "committees": ["House Appropriations", "Senate Appropriations"], "introduced": 1185768000, "type": "HR", "id": "110_HR3222"}]}], "registrant": "K&L GATES LLP", "alternate_name": "SYNOSIA THERAPEUTICS INC"}, {"received": 1208524388, "issue_codes": [], "type": "FIRST QUARTER (NO ACTIVITY)", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "1st Quarter (Jan 1 - Mar 31)", "id": "B87004D2-E307-4992-A7A6-3697CD5B7B0B", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"B87004D2-E307-4992-A7A6-3697CD5B7B0B": {"client": {"total": 1}, "specific_issues": {"total": 1, "twiyhXwYRTAEFuychXHRMo": {}}}}, "year": 2008, "specific_issues": [{"text": "", "gov_entities": [], "id": "twiyhXwYRTAEFuychXHRMo", "year": 2008}], "registrant": "The Cohen Group", "alternate_name": "International Golden Group"}, {"received": 1238533561, "issue_codes": [], "type": "SECOND QUARTER (NO ACTIVITY)", "client_name": "LYTIX BIOPHARMA AS", "period": "2nd Quarter (Apr 1 - June 30)", "id": "EE519D16-949C-40FA-BA51-C29BC79184CA", "amount": null, "client": {"legal_name": "LYTIX BIOPHARMA AS", "name": "LYTEX BIOPHARMA AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO985889635"}, "meta": {"EE519D16-949C-40FA-BA51-C29BC79184CA": {"client": {"total": 1}, "specific_issues": {"total": 1, "bKTrRdmVSbfowkxTNpYjKN": {}}}}, "year": 2008, "specific_issues": [{"text": "", "gov_entities": [], "id": "bKTrRdmVSbfowkxTNpYjKN", "year": 2008}], "registrant": "American Defense International, Inc.", "alternate_name": "LYTEX BIOPHARMA AS"}, {"received": 1224106936, "issue_codes": [], "type": "THIRD QUARTER (NO ACTIVITY)", "client_name": "LYTIX BIOPHARMA AS", "period": "3rd Quarter (July 1 - Sep 30)", "id": "FCA37BD6-EB47-427D-9A5E-5177817725CE", "amount": null, "client": {"legal_name": "LYTIX BIOPHARMA AS", "name": "LYTEX BIOPHARMA AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO985889635"}, "meta": {"FCA37BD6-EB47-427D-9A5E-5177817725CE": {"client": {"total": 1}, "specific_issues": {"total": 1, "tcD8EEKmJCbqssAPe5deHd": {}}}}, "year": 2008, "specific_issues": [{"text": "", "gov_entities": [], "id": "tcD8EEKmJCbqssAPe5deHd", "year": 2008}], "registrant": "American Defense International, Inc.", "alternate_name": "LYTEX BIOPHARMA AS"}, {"received": 1187031679, "issue_codes": ["BUD"], "type": "REGISTRATION", "client_name": "BIOTIE THERAPIES AG", "period": "UNDETERMINED", "id": "19F6A1BB-51B4-490E-A0A7-4C85C1A30F4F", "amount": null, "client": {"legal_name": "BIOTIE THERAPIES AG", "name": "SYNOSIA THERAPEUTICS INC", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "CHCHE113909392"}, "meta": {"19F6A1BB-51B4-490E-A0A7-4C85C1A30F4F": {"client": {"total": 1}, "specific_issues": {"total": 1, "bQkGGRGvAycxcoBMN4nHNn": {}}}}, "year": 2007, "specific_issues": [{"text": "Explore potential federal business development opportunities including grants, contracts and appropriations.", "issue": "BUD", "id": "bQkGGRGvAycxcoBMN4nHNn", "lobbyists": ["AUDAP, BRANDON Joseph", "MCCAIN, STEVEN", "RITTER, DANIEL"], "year": 2007}], "registrant": "K&L GATES LLP", "alternate_name": "SYNOSIA THERAPEUTICS INC"}, {"received": 1186668410, "issue_codes": ["DEF"], "type": "MID-YEAR REPORT", "client_name": "LAURAS AS", "period": "Mid-Year (Jan 1 - Jun 30)", "id": "37F22A44-9250-49D0-BB11-B1CBCEEFC0FB", "amount": 40000, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"37F22A44-9250-49D0-BB11-B1CBCEEFC0FB": {"client": {"total": 1}, "specific_issues": {"total": 1, "nZp6hwbr54NoeM4wjTYQUa": {}}}}, "year": 2007, "specific_issues": [{"text": "National Defense Authorization Act for FY08, provisions relating to HIV therapy. Department of Defense Appropriations Bill for FY08, provisions relating to HIV therapy.", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["Barth, John", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "PRESSNELL, ELIZABETH \"Sissy\""], "year": 2007, "issue": "DEF", "id": "nZp6hwbr54NoeM4wjTYQUa"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1202912031, "issue_codes": ["DEF"], "type": "YEAR-END REPORT", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "Year-End (July 1 - Dec 31)", "id": "3D318314-F15A-412E-B3A0-6CF09E9A8976", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"3D318314-F15A-412E-B3A0-6CF09E9A8976": {"client": {"total": 1}, "specific_issues": {"total": 1, "nJ8RgCya3ZwCw2AeJQtQBS": {}}}}, "alternate_name": "International Golden Group", "year": 2007, "specific_issues": [{"text": "U.S. Government policies regarding international cooperation on defense and critical infrastruture protection.", "gov_entities": ["Defense, Dept of (DOD)", "State, Dept of (DOS)"], "lobbyists": ["BODNER, JAMES M", "LOY, JAMES M", "SEBRIGHT, DANNY"], "year": 2007, "issue": "DEF", "id": "nJ8RgCya3ZwCw2AeJQtQBS"}], "registrant": "The Cohen Group", "foreign_entities": ["SEVEN EMIRATES FOR INVESTMENT & INT TRADING", "AL MAYASSAH FINANCIAL INVESTMENT LLC"]}, {"received": 1202525380, "issue_codes": ["BUD", "DEF"], "type": "YEAR-END REPORT", "client_name": "BIOTIE THERAPIES AG", "period": "Year-End (July 1 - Dec 31)", "id": "79220AC0-EF4C-4A37-8C6A-F9A5BC16FCF7", "amount": 20000, "client": {"legal_name": "BIOTIE THERAPIES AG", "name": "SYNOSIA THERAPEUTICS INC", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "CHCHE113909392"}, "meta": {"79220AC0-EF4C-4A37-8C6A-F9A5BC16FCF7": {"client": {"total": 1}, "specific_issues": {"oiDzpggbrAR8w8VHzDNjtE": {"bills_by_algo": {"total": 1, "110_HR3222": {"sponsor": {"total": 1}}}}, "total": 2, "VzxcB7uiq437zFkSCajwVD": {"bills_by_algo": {"total": 1, "110_HR3222": {"sponsor": {"total": 1}}}}}}}, "year": 2007, "specific_issues": [{"text": "Congressionally Directed Medical Research Programs and HR 3222, DOD Appropriatioins for FY08, explore potential federal business development opportunities including grants, contracts and appropriations. PTSD Research.", "id": "oiDzpggbrAR8w8VHzDNjtE", "gov_entities": ["Defense, Dept of (DOD)", "HOUSE OF REPRESENTATIVES", "SENATE", "Veterans Affairs, Dept of (VA)"], "lobbyists": ["AUDAP, BRANDON Joseph", "GITSHAM, DENISE", "HEIMAN, BRUCE", "MCCAIN, STEVEN", "Olivares, Edward Charles Jr", "RITTER, DANIEL", "STIMERS, PAUL"], "year": 2007, "issue": "DEF", "bills_by_algo": [{"public_law": "110-116", "titles": ["Making appropriations for the Department of Defense for the fiscal year ending September 30, 2008, and for other purposes.", "Department of Defense Appropriations Act, 2008", "Border Security First Act of 2007", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008"], "top_terms": ["Armed forces and national security", "AIDS (Disease)"], "number": 3222, "session": 110, "sponsor": {"firstname": "John", "district": 12, "title": "rep", "lastname": "Murtha", "religion": "Catholic", "state": "PA", "gender": "M", "party": "Democrat", "id": 400286}, "committees": ["House Appropriations", "Senate Appropriations"], "introduced": 1185768000, "type": "HR", "id": "110_HR3222"}]}, {"text": "Congressionally Directed Medical Research Programs and HR 3222, DOD Appropriatioins for FY08, explore potential federal business development opportunities including grants, contracts and appropriations. PTSD Research.", "id": "VzxcB7uiq437zFkSCajwVD", "gov_entities": ["Defense, Dept of (DOD)", "HOUSE OF REPRESENTATIVES", "SENATE", "Veterans Affairs, Dept of (VA)"], "lobbyists": ["AUDAP, BRANDON Joseph", "GITSHAM, DENISE", "HEIMAN, BRUCE", "MCCAIN, STEVEN", "Olivares, Edward Charles Jr", "RITTER, DANIEL", "STIMERS, PAUL"], "year": 2007, "issue": "BUD", "bills_by_algo": [{"public_law": "110-116", "titles": ["Making appropriations for the Department of Defense for the fiscal year ending September 30, 2008, and for other purposes.", "Department of Defense Appropriations Act, 2008", "Border Security First Act of 2007", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008", "Department of Defense Appropriations Act, 2008"], "top_terms": ["Armed forces and national security", "AIDS (Disease)"], "number": 3222, "session": 110, "sponsor": {"firstname": "John", "district": 12, "title": "rep", "lastname": "Murtha", "religion": "Catholic", "state": "PA", "gender": "M", "party": "Democrat", "id": 400286}, "committees": ["House Appropriations", "Senate Appropriations"], "introduced": 1185768000, "type": "HR", "id": "110_HR3222"}]}], "registrant": "K&L GATES LLP", "alternate_name": "SYNOSIA THERAPEUTICS INC"}, {"received": 1187112833, "issue_codes": ["BUD"], "type": "MID-YEAR REPORT", "client_name": "BIOTIE THERAPIES AG", "period": "Mid-Year (Jan 1 - Jun 30)", "id": "0576EB49-2646-4AF7-8722-FBAD54666935", "amount": null, "client": {"legal_name": "BIOTIE THERAPIES AG", "name": "SYNOSIA THERAPEUTICS INC", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "CHCHE113909392"}, "meta": {"0576EB49-2646-4AF7-8722-FBAD54666935": {"client": {"total": 1}, "specific_issues": {"hHoShRxcFyCtGbZ8C82SsA": {}, "total": 1}}}, "year": 2007, "specific_issues": [{"text": "Explore potential federal business development opportunities including grants, contracts and appropriations.", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["AUDAP, BRANDON Joseph", "MCCAIN, STEVEN", "RITTER, DANIEL"], "year": 2007, "issue": "BUD", "id": "hHoShRxcFyCtGbZ8C82SsA"}], "registrant": "K&L GATES LLP", "alternate_name": "SYNOSIA THERAPEUTICS INC"}, {"received": 1186507347, "issue_codes": ["DEF"], "type": "MID-YEAR REPORT", "client_name": "ACE BIOSCIENCES A/S", "period": "Mid-Year (Jan 1 - Jun 30)", "id": "2E52A1B0-88BE-456B-9921-B40AA9A59ACA", "amount": 40000, "client": {"legal_name": "ACE BIOSCIENCES A/S", "name": "ACE BIOSCIENCES AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "DK25616715"}, "meta": {"2E52A1B0-88BE-456B-9921-B40AA9A59ACA": {"client": {"total": 1}, "specific_issues": {"total": 1, "YyhRR2MjVjU2RkCGhadj4e": {}}}}, "year": 2007, "specific_issues": [{"text": "Department of Defense Authorization Act, provisions relating to campylobacter vaccines. Department of Defense Appropriations Act, provisions relating to campylobacter vaccines.", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["Barth, John", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "PRESSNELL, ELIZABETH \"Sissy\""], "year": 2007, "issue": "DEF", "id": "YyhRR2MjVjU2RkCGhadj4e"}], "registrant": "American Defense International, Inc.", "alternate_name": "ACE BIOSCIENCES AS"}, {"received": 1179265153, "issue_codes": ["DEF"], "type": "REGISTRATION", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "UNDETERMINED", "id": "DA15F19C-069D-4098-BAB3-A27F62DDC266", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"DA15F19C-069D-4098-BAB3-A27F62DDC266": {"client": {"total": 1}, "specific_issues": {"iywQH4qS8jYP9YYpVx2PiC": {}, "total": 1}}}, "year": 2007, "specific_issues": [{"text": "U.S. Government policies and positions regarding defense cooperation.", "issue": "DEF", "id": "iywQH4qS8jYP9YYpVx2PiC", "lobbyists": ["BODNER, JAMES M", "LOY, JAMES M", "SEBRIGHT, DANNY"], "year": 2007}], "registrant": "The Cohen Group", "alternate_name": "International Golden Group"}, {"received": 1202922687, "issue_codes": ["DEF"], "type": "YEAR-END REPORT", "client_name": "LAURAS AS", "period": "Year-End (July 1 - Dec 31)", "id": "E6915552-B6F1-4CDB-BEEC-8E3BD2AB1AE1", "amount": 40000, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"E6915552-B6F1-4CDB-BEEC-8E3BD2AB1AE1": {"client": {"total": 1}, "specific_issues": {"total": 1, "q8nYAfVx97vPpskppVoLdb": {}}}}, "year": 2007, "specific_issues": [{"text": "National Defense Authorization Act, provisions relating to HIV therapy. Department of Defense Appropriations Bill, provisions relating to HIV therapy.", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["Barth, John", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "PRESSNELL, ELIZABETH \"Sissy\""], "year": 2007, "issue": "DEF", "id": "q8nYAfVx97vPpskppVoLdb"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1202746136, "issue_codes": ["DEF"], "type": "YEAR-END TERMINATION", "client_name": "ACE BIOSCIENCES A/S", "period": "Year-End (July 1 - Dec 31)", "id": "F4F0D135-410F-4DB1-937B-C4A0B923E8BB", "amount": 40000, "client": {"legal_name": "ACE BIOSCIENCES A/S", "name": "ACE BIOSCIENCES AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "DK25616715"}, "meta": {"F4F0D135-410F-4DB1-937B-C4A0B923E8BB": {"client": {"total": 1}, "specific_issues": {"FgoD5cFEbiBsRGtcakdbgf": {}, "total": 1}}}, "year": 2007, "specific_issues": [{"text": "Department of Defense Authorization Act, provisions relating to campylobacter vaccines. Department of Defense Appropriations Act, provisions relating to campylobacter vaccines.", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["Barth, John", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "PRESSNELL, ELIZABETH \"Sissy\""], "year": 2007, "issue": "DEF", "id": "FgoD5cFEbiBsRGtcakdbgf"}], "registrant": "American Defense International, Inc.", "alternate_name": "ACE BIOSCIENCES AS"}, {"received": 1186520508, "issue_codes": ["DEF"], "type": "MID-YEAR REPORT", "client_name": "INTERNATIONAL GOLDEN GROUP PJSC", "period": "Mid-Year (Jan 1 - Jun 30)", "id": "E072E518-8ADD-4110-B47F-1BD1EA5C2431", "amount": null, "client": {"legal_name": "INTERNATIONAL GOLDEN GROUP PJSC", "name": "International Golden Group", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "AE0000417477"}, "meta": {"E072E518-8ADD-4110-B47F-1BD1EA5C2431": {"client": {"total": 1}, "specific_issues": {"hNFsxexmfwnRfvf6vcTQN6": {}, "total": 1}}}, "year": 2007, "specific_issues": [{"text": "U.S. Government policies and positions regarding defense cooperation.", "gov_entities": ["Defense, Dept of (DOD)", "State, Dept of (DOS)"], "lobbyists": ["BODNER, JAMES M", "LOY, JAMES M", "SEBRIGHT, DANNY"], "year": 2007, "issue": "DEF", "id": "hNFsxexmfwnRfvf6vcTQN6"}], "registrant": "The Cohen Group", "alternate_name": "International Golden Group"}, {"received": 1174505757, "issue_codes": ["DEF"], "type": "REGISTRATION", "client_name": "ACE BIOSCIENCES A/S", "period": "UNDETERMINED", "id": "DE51FECD-0F6F-4370-AD9C-6A2B70F3A775", "amount": null, "client": {"legal_name": "ACE BIOSCIENCES A/S", "name": "ACE BIOSCIENCES AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "DK25616715"}, "meta": {"DE51FECD-0F6F-4370-AD9C-6A2B70F3A775": {"client": {"total": 1}, "specific_issues": {"FXKjhRL3VreVDiK4M2bPUH": {}, "total": 1}}}, "year": 2007, "specific_issues": [{"text": "Department of Defense Authorization Act, provisions relating to campylobacter vaccines. Department of Defense Appropriations Act, provisions relating to campylobacter vaccines.", "issue": "DEF", "id": "FXKjhRL3VreVDiK4M2bPUH", "lobbyists": ["Barth, John", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "NORTON, NANCY", "PRESSNELL, ELIZABETH \"Sissy\""], "year": 2007}], "registrant": "American Defense International, Inc.", "alternate_name": "ACE BIOSCIENCES AS"}, {"received": 1202771357, "issue_codes": ["DEF"], "type": "YEAR-END REPORT", "client_name": "LYTIX BIOPHARMA AS", "period": "Year-End (July 1 - Dec 31)", "id": "E4CE7062-C6BB-4186-8996-4141D9624FC2", "amount": 60000, "client": {"legal_name": "LYTIX BIOPHARMA AS", "name": "LYTEX BIOPHARMA AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO985889635"}, "meta": {"E4CE7062-C6BB-4186-8996-4141D9624FC2": {"client": {"total": 1}, "specific_issues": {"dM6SfmNHTaoGR2cPdGPx6L": {}, "total": 1}}}, "year": 2007, "specific_issues": [{"text": "Meetings with officials regarding their anti-microbial and novel cancer drugs.", "gov_entities": ["Defense, Dept of (DOD)"], "lobbyists": ["Barth, John", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "PRESSNELL, ELIZABETH \"Sissy\""], "year": 2007, "issue": "DEF", "id": "dM6SfmNHTaoGR2cPdGPx6L"}], "registrant": "American Defense International, Inc.", "alternate_name": "LYTEX BIOPHARMA AS"}, {"received": 1186501159, "issue_codes": ["DEF"], "type": "MID-YEAR REPORT", "client_name": "LYTIX BIOPHARMA AS", "period": "Mid-Year (Jan 1 - Jun 30)", "id": "EE692281-BAD9-4DBD-A2A5-1AB1FCD5F043", "amount": 20000, "client": {"legal_name": "LYTIX BIOPHARMA AS", "name": "LYTEX BIOPHARMA AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO985889635"}, "meta": {"EE692281-BAD9-4DBD-A2A5-1AB1FCD5F043": {"client": {"total": 1}, "specific_issues": {"total": 1, "wT7kQLJ6E48sAVYk3aujNW": {}}}}, "year": 2007, "specific_issues": [{"text": "Meetings with officials regarding their anti-microbial and novel cancer drugs.", "gov_entities": ["Defense, Dept of (DOD)"], "lobbyists": ["Barth, John", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "PRESSNELL, ELIZABETH \"Sissy\""], "year": 2007, "issue": "DEF", "id": "wT7kQLJ6E48sAVYk3aujNW"}], "registrant": "American Defense International, Inc.", "alternate_name": "LYTEX BIOPHARMA AS"}, {"received": 1182353339, "issue_codes": ["DEF"], "type": "REGISTRATION", "client_name": "LYTIX BIOPHARMA AS", "period": "UNDETERMINED", "id": "F585C6D6-3DF1-46E7-B87F-F6E151995D67", "amount": null, "client": {"legal_name": "LYTIX BIOPHARMA AS", "name": "LYTEX BIOPHARMA AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO985889635"}, "meta": {"F585C6D6-3DF1-46E7-B87F-F6E151995D67": {"client": {"total": 1}, "specific_issues": {"total": 1, "BPfJEC4wH7s76DvJdGXELn": {}}}}, "year": 2007, "specific_issues": [{"text": "Meetings with officials regarding their anti-microbial and novel cancer drugs.", "issue": "DEF", "id": "BPfJEC4wH7s76DvJdGXELn", "lobbyists": ["Barth, John", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "NORTON, NANCY", "PRESSNELL, ELIZABETH \"Sissy\""], "year": 2007}], "registrant": "American Defense International, Inc.", "alternate_name": "LYTEX BIOPHARMA AS"}, {"received": 1155009600, "issue_codes": ["DEF"], "type": "MID-YEAR REPORT", "client_name": "LAURAS AS", "period": "Mid-Year (Jan 1 - Jun 30)", "id": "216A5D1D-528B-4B1E-A32A-60A01B0C8441", "amount": 20000, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"216A5D1D-528B-4B1E-A32A-60A01B0C8441": {"client": {"total": 1}, "specific_issues": {"total": 1, "fViVekEPfW2TXSEKLq82e4": {}}}}, "year": 2006, "specific_issues": [{"text": "", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["Barth, John", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "NORTON, NANCY", "PRESSNELL, ELIZABETH \"Sissy\""], "year": 2006, "issue": "DEF", "id": "fViVekEPfW2TXSEKLq82e4"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1171405773, "issue_codes": ["DEF"], "type": "YEAR-END REPORT", "client_name": "LAURAS AS", "period": "Year-End (July 1 - Dec 31)", "id": "D3A56789-FCAC-4422-95CA-68487089202B", "amount": 20000, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"D3A56789-FCAC-4422-95CA-68487089202B": {"client": {"total": 1}, "specific_issues": {"total": 1, "8rbjujmGNHEadawXoRU7k4": {}}}}, "year": 2006, "specific_issues": [{"text": "National Defense Authorization Act for FY07, provisions relating to HIV therapy. Department of Defense Appropriations Bill for FY07, provisions relating to HIV therapy.", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["Barth, John", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "NORTON, NANCY", "PRESSNELL, ELIZABETH \"Sissy\""], "year": 2006, "issue": "DEF", "id": "8rbjujmGNHEadawXoRU7k4"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1139893200, "issue_codes": ["DEF"], "type": "YEAR-END REPORT", "client_name": "LAURAS AS", "period": "Year-End (July 1 - Dec 31)", "id": "B42D8376-BC5D-4E70-9E83-E1D615EBDC5B", "amount": 40000, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"B42D8376-BC5D-4E70-9E83-E1D615EBDC5B": {"client": {"total": 1}, "specific_issues": {"total": 1, "VBMQ5pXZVSiZaNcXcuC8Ec": {}}}}, "year": 2005, "specific_issues": [{"text": "", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["Barth, John", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "MARSH, WILL", "NORTON, NANCY", "PRESSNELL, ELIZABETH \"Sissy\""], "year": 2005, "issue": "DEF", "id": "VBMQ5pXZVSiZaNcXcuC8Ec"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1124078400, "issue_codes": ["DEF"], "type": "MID-YEAR REPORT", "client_name": "LAURAS AS", "period": "Mid-Year (Jan 1 - Jun 30)", "id": "CF159A6A-86F2-4B3F-BDDC-75CE4470A21E", "amount": 40000, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"CF159A6A-86F2-4B3F-BDDC-75CE4470A21E": {"client": {"total": 1}, "specific_issues": {"total": 1, "E3s7qcGvhYpR3N5EoMbkpC": {}}}}, "year": 2005, "specific_issues": [{"text": "", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["COOPER, ETHAN JR", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "MARSH, WILL"], "year": 2005, "issue": "DEF", "id": "E3s7qcGvhYpR3N5EoMbkpC"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1108357200, "issue_codes": ["DEF"], "type": "YEAR-END REPORT", "client_name": "LAURAS AS", "period": "Year-End (July 1 - Dec 31)", "id": "14432D17-6A82-40CD-9F11-98A08FEF53F8", "amount": 40000, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"14432D17-6A82-40CD-9F11-98A08FEF53F8": {"client": {"total": 1}, "specific_issues": {"total": 1, "jLbCtCsNUUcX84s7mWwwdh": {}}}}, "year": 2004, "specific_issues": [{"text": "", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["COOPER, ETHAN JR", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "MARSH, WILL"], "year": 2004, "issue": "DEF", "id": "jLbCtCsNUUcX84s7mWwwdh"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1092369600, "issue_codes": ["DEF"], "type": "MID-YEAR REPORT", "client_name": "LAURAS AS", "period": "Mid-Year (Jan 1 - Jun 30)", "id": "49BA3D85-E29A-4D97-A2A2-58DBB7560AC6", "amount": 40000, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"49BA3D85-E29A-4D97-A2A2-58DBB7560AC6": {"client": {"total": 1}, "specific_issues": {"total": 1, "dG2fgwhvayPciGBrLCwexD": {}}}}, "year": 2004, "specific_issues": [{"text": "", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["COOPER, ETHAN JR", "HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "MARSH, WILL"], "year": 2004, "issue": "DEF", "id": "dG2fgwhvayPciGBrLCwexD"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1068699600, "issue_codes": ["HCR", "DEF"], "type": "REGISTRATION", "client_name": "LAURAS AS", "period": "UNDETERMINED", "id": "2DB9687C-4D3A-46B1-B656-25C51A9DEF23", "amount": null, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"2DB9687C-4D3A-46B1-B656-25C51A9DEF23": {"client": {"total": 1}, "specific_issues": {"6P38nPaPdFUoeQx6Xeeo4T": {}, "N8VBNyWMuSZDkaTVQamkoV": {}, "total": 2}}}, "year": 2003, "specific_issues": [{"text": "", "issue": "HCR", "id": "6P38nPaPdFUoeQx6Xeeo4T", "lobbyists": ["HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "MARSH, WILL"], "year": 2003}, {"text": "", "issue": "DEF", "id": "N8VBNyWMuSZDkaTVQamkoV", "lobbyists": ["HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "MARSH, WILL"], "year": 2003}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1076994000, "issue_codes": ["HCR", "DEF"], "type": "YEAR-END REPORT", "client_name": "LAURAS AS", "period": "Year-End (July 1 - Dec 31)", "id": "C3902AD6-DF4D-4EE2-9CD6-2AAABA86EA9A", "amount": 20000, "client": {"legal_name": "LAURAS AS", "name": "LAURAS AS", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "NO980288765"}, "meta": {"C3902AD6-DF4D-4EE2-9CD6-2AAABA86EA9A": {"client": {"total": 1}, "specific_issues": {"VN8t5BBKgoa9ivHsZWHzSi": {}, "mxGTfTXLFtip8fcmxYxmNJ": {}, "total": 2}}}, "year": 2003, "specific_issues": [{"text": "", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "MARSH, WILL"], "year": 2003, "issue": "DEF", "id": "mxGTfTXLFtip8fcmxYxmNJ"}, {"text": "", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["HERSON, MICHAEL", "HIPP, VAN JR", "KHATCHADURIAN, MICHAEL", "MARSH, WILL"], "year": 2003, "issue": "HCR", "id": "VN8t5BBKgoa9ivHsZWHzSi"}], "registrant": "American Defense International, Inc.", "alternate_name": "LAURAS AS"}, {"received": 1030334400, "issue_codes": ["HCR"], "type": "MID-YEAR TERMINATION (NO ACTIVITY)", "client_name": "LIMITED LIABILITY COMPANY PPD DEVELOPMENT (SMOLENSK)", "period": "Mid-Year (Jan 1 - Jun 30)", "id": "416A9579-B1A1-4D40-8446-9936565FA6CB", "amount": 0, "client": {"legal_name": "LIMITED LIABILITY COMPANY PPD DEVELOPMENT (SMOLENSK)", "name": "PPD DEVELOPMENT", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "RU83994794"}, "meta": {"416A9579-B1A1-4D40-8446-9936565FA6CB": {"client": {"total": 1}, "specific_issues": {"total": 1, "jeGavswJomRu5CtzBXSqV9": {}}}}, "year": 2002, "specific_issues": [{"text": "", "gov_entities": ["Agency for Health Care Policy & Research", "Centers For Disease Control & Prevention (CDC)", "Centers For Medicare and Medicaid Services (CMS)", "Food & Drug Administration (FDA)", "Health & Human Services, Dept of (HHS)", "Homeland Security, Dept of (DHS)", "HOUSE OF REPRESENTATIVES", "Natl Institutes of Health (NIH)", "SENATE", "Veterans Affairs, Dept of (VA)"], "lobbyists": ["PEDDICORD, DOUGLAS", "SPIELBERG, DEBORAH", "VENETOULIS, LYNN MORRISON"], "year": 2002, "issue": "HCR", "id": "jeGavswJomRu5CtzBXSqV9"}], "registrant": "Washington Health Advocates", "alternate_name": "PPD DEVELOPMENT"}, {"received": 1011934800, "issue_codes": ["HCR"], "type": "YEAR-END REPORT", "client_name": "LIMITED LIABILITY COMPANY PPD DEVELOPMENT (SMOLENSK)", "period": "Year-End (July 1 - Dec 31)", "id": "7586CFE2-C98F-44E3-B129-C731236A2C95", "amount": null, "client": {"legal_name": "LIMITED LIABILITY COMPANY PPD DEVELOPMENT (SMOLENSK)", "name": "PPD DEVELOPMENT", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "RU83994794"}, "meta": {"7586CFE2-C98F-44E3-B129-C731236A2C95": {"client": {"total": 1}, "specific_issues": {"a5HXGqb8BRP6BoSpN9jYVJ": {}, "total": 1}}}, "year": 2001, "specific_issues": [{"text": "", "gov_entities": ["HOUSE OF REPRESENTATIVES", "SENATE"], "lobbyists": ["PEDDICORD, DOUGLAS"], "year": 2001, "issue": "HCR", "id": "a5HXGqb8BRP6BoSpN9jYVJ"}], "registrant": "Washington Health Advocates", "alternate_name": "PPD DEVELOPMENT"}, {"received": 1011934800, "issue_codes": ["HCR"], "type": "REGISTRATION", "client_name": "LIMITED LIABILITY COMPANY PPD DEVELOPMENT (SMOLENSK)", "period": "UNDETERMINED", "id": "0AFDD90E-2DE0-4DE1-941A-2EB88F963431", "amount": null, "client": {"legal_name": "LIMITED LIABILITY COMPANY PPD DEVELOPMENT (SMOLENSK)", "name": "PPD DEVELOPMENT", "naics": "541711", "gvkey": null, "ticker": null, "id": null, "bvdid": "RU83994794"}, "meta": {"0AFDD90E-2DE0-4DE1-941A-2EB88F963431": {"client": {"total": 1}, "specific_issues": {"RBUHC4DqcAbJbJESdnm7H6": {}, "total": 1}}}, "year": 2001, "specific_issues": [{"text": "", "issue": "HCR", "id": "RBUHC4DqcAbJbJESdnm7H6", "lobbyists": ["PEDDICORD, DOUGLAS"], "year": 2001}], "registrant": "Washington Health Advocates", "alternate_name": "PPD DEVELOPMENT"}]